Literature DB >> 2981538

"Concomitant immunity" in murine tumours of non-detectable immunogenicity.

R A Ruggiero, O D Bustuoabad, R D Bonfil, R P Meiss, C D Pasqualini.   

Abstract

Various immunization assays were used to demonstrate the lack of immunogenicity of three BALB/c tumours of spontaneous origin and of a fourth one resulting from foreign body tumorigenesis. All four tumours inhibited the growth of a second implant of the same tumour into the contralateral flank. In our tumour models "concomitant immunity" (1) was not mediated by macrophage or T-cell dependent immune reactions: both thymectomized BALB/c and nude mice (treated or untreated with silica) gave the same results as intact mice; (2) showed some degree of non-specificity, inhibiting the growth of a different tumour in 3/4 cases; though, the existence of a specific component could not be discarded; (3) was proportional to the volume of the primary tumour at the time of the second challenge; (4) was dependent on actively growing primary tumour, not being obtained with progressively increasing daily inocula of irradiated tumour cells; (5) was detectable in an actively growing secondary tumour; recurrent growth after partial surgical excision was inhibited and (6) involved cytostasis of the secondary tumour: a syngeneic graft of the overlying skin led to tumour growth while histological studies revealed the presence of viable tumour cells. It is postulated that "concomitant immunity" or resistance can be generated without the active participation of the immune system and that tumour-related factors are, in certain cases, responsible for blocking the growth of secondary tumours.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2981538      PMCID: PMC1976815          DOI: 10.1038/bjc.1985.6

Source DB:  PubMed          Journal:  Br J Cancer        ISSN: 0007-0920            Impact factor:   7.640


  20 in total

1.  Quantitative study of the granulopectic activity of the reticulo-endothelial system. II. A study of the kinetics of the R. E. S. in relation to the dose of carbon injected; relationship between the weight of the organs and their activity.

Authors:  G BIOZZI; B BENACERRAF; B N HALPERN
Journal:  Br J Exp Pathol       Date:  1953-08

2.  Immunology of spontaneous mammary carcinomas in mice. V. Acquired tumor resistance and enhancement in strain A mice infected with mammary tumor virus.

Authors:  M A Attia; D W Weiss
Journal:  Cancer Res       Date:  1966-08       Impact factor: 12.701

3.  Tumor development in mice bearing a plastic cylinder and inoculated with human neoplastic cells.

Authors:  C D Pasqualini; L Sen; F Saal; L Schwartz; L Z Tkaczevski
Journal:  J Natl Cancer Inst       Date:  1973-07       Impact factor: 13.506

4.  The effect of tumor size on concomitant tumor immunity.

Authors:  P J Deckers; R C Davis; G A Parker; J A Mannick
Journal:  Cancer Res       Date:  1973-01       Impact factor: 12.701

5.  Concomitant immunity to syngeneic methylcholanthrene-induced tumours in mice. Occurrence and specificity of concomitant immunity.

Authors:  R Kearney; D S Nelson
Journal:  Aust J Exp Biol Med Sci       Date:  1973-12

6.  Concomitant immunity and specific depression of immunity by residual or reinjected syngeneic tumor tissue.

Authors:  J Vaage
Journal:  Cancer Res       Date:  1971-11       Impact factor: 12.701

7.  Role of preoperative irradiation in prolonging concomitant immunity and preventing metastasis in mice.

Authors:  G Crile; S D Deodhar
Journal:  Cancer       Date:  1971-03       Impact factor: 6.860

8.  Co-existence of allogeneic tumour growth and homograft immunity in man.

Authors:  C M Southam
Journal:  Eur J Cancer       Date:  1968-10       Impact factor: 9.162

Review 9.  Concomitant tumor immunity and the resistance to a second tumor challenge.

Authors:  E Gorelik
Journal:  Adv Cancer Res       Date:  1983       Impact factor: 6.242

10.  An examination of the cytotoxic effects of silica on macrophages.

Authors:  A C Allison; J S Harington; M Birbeck
Journal:  J Exp Med       Date:  1966-08-01       Impact factor: 14.307

View more
  17 in total

1.  Characterization of the immunophenotype and the metastatic properties of a murine T-lymphoma cell line. Unexpected expression of cytoplasmatic CD4.

Authors:  C Mongini; P Ruybal; M J Gravisaco; M Croci; M Sánchez Lockhart; V Fabris; A C Waldner
Journal:  In Vitro Cell Dev Biol Anim       Date:  2001-09       Impact factor: 2.416

2.  Tumor necrosis can facilitate the appearance of metastases.

Authors:  R D Bonfil; O D Bustuoabad; R A Ruggiero; R P Meiss; C D Pasqualini
Journal:  Clin Exp Metastasis       Date:  1988 Mar-Apr       Impact factor: 5.150

3.  Induction of an autoimmune response against syngeneic lymphoma cells by immunogenic 64-kDa protein isolated from normal blast cells of BALB/c mice.

Authors:  R Stock; D Naor
Journal:  Cancer Immunol Immunother       Date:  1995-01       Impact factor: 6.968

4.  Evidence for a narrow range of growth patterns of malignant tumors and embryos of different species.

Authors:  I D Bassukas
Journal:  Naturwissenschaften       Date:  1993-08

5.  Biphasic effect of a primary tumor on the growth of secondary tumor implants.

Authors:  Juan Bruzzo; Paula Chiarella; Roberto P Meiss; Raúl A Ruggiero
Journal:  J Cancer Res Clin Oncol       Date:  2010-02-21       Impact factor: 4.553

6.  Mathematical Modeling of Tumor-Tumor Distant Interactions Supports a Systemic Control of Tumor Growth.

Authors:  Sebastien Benzekry; Clare Lamont; Dominique Barbolosi; Lynn Hlatky; Philip Hahnfeldt
Journal:  Cancer Res       Date:  2017-07-20       Impact factor: 12.701

7.  Mechanisms of tumour rejection in the murine DBA/2-SL2 concomitant immunity system.

Authors:  D Characiejus; H F Dullens; W Den Otter
Journal:  Cancer Immunol Immunother       Date:  1990       Impact factor: 6.968

8.  A theoretical explanation of "concomitant resistance".

Authors:  S Michelson; J T Leith
Journal:  Bull Math Biol       Date:  1995-09       Impact factor: 1.758

9.  Primary melanoma tumor inhibits metastasis through alterations in systemic hemostasis.

Authors:  Jennifer M Kirstein; M Nicole Hague; Patricia M McGowan; Alan B Tuck; Ann F Chambers
Journal:  J Mol Med (Berl)       Date:  2016-04-06       Impact factor: 4.599

10.  Therapeutic anti-tumor vaccines: from tumor inhibition to enhancement.

Authors:  Paula Chiarella; Verónica Reffo; Juan Bruzzo; Oscar D Bustuoabad; Raúl A Ruggiero
Journal:  Clin Med Oncol       Date:  2008-04-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.